Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Rahel S. König, Werner C. Albrich, Christian R. Kahlert, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2725
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 66
The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome
Monica Montagnani, Lucrezia Bottalico, Maria Assunta Potenza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10322-10322
Open Access | Times Cited: 54
Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
Meenakshi Kandpal, Omkar Indari, Budhadev Baral, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1064-1064
Open Access | Times Cited: 69
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 32
Systemic Inflammation as the Health-Related Communication Tool Between the Human Host and Gut Microbiota in the Framework of Predictive, Preventive, and Personalized Medicine
Payam Behzadi, Verónica I. Dodero, Olga Golubnitschaja
Advances in predictive, preventive and personalised medicine (2024), pp. 203-241
Closed Access | Times Cited: 14
Tropical postbiotics alleviate the disorders in the gut microbiota and kidney damage induced by ochratoxin A exposure
Shuaiming Jiang, Lingwei Du, Zhao Qian, et al.
Food & Function (2024) Vol. 15, Iss. 8, pp. 3980-3992
Closed Access | Times Cited: 9
Good girl goes bad: Understanding how gut commensals cause disease
Priyankar Dey
Microbial Pathogenesis (2024) Vol. 190, pp. 106617-106617
Closed Access | Times Cited: 9
The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives
Andreas Stallmach, Stefanie Quickert, Christian Puta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Understanding myalgic encephalomyelitis
Sonya Marshall‐Gradisnik, Natalie Eaton-Fitch
Science (2022) Vol. 377, Iss. 6611, pp. 1150-1151
Open Access | Times Cited: 34
Interactions between Gut Microbiota and Polyphenols: New Insights into the Treatment of Fatigue
Chuanhong Luo, Xichuan Wei, Jiao Song, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7377-7377
Open Access | Times Cited: 30
The Association between Dysbiosis and Neurological Conditions Often Manifesting with Chronic Pain
Mary Garvey
Biomedicines (2023) Vol. 11, Iss. 3, pp. 748-748
Open Access | Times Cited: 21
Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID
Warren P. Tate, Max Walker, Katie Peppercorn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5124-5124
Open Access | Times Cited: 20
Saliva and tongue microbiota in burning mouth syndrome: An exploratory study of potential roles
Shuangshuang Wu, Linman Li, Xu Wang, et al.
Oral Diseases (2024)
Closed Access | Times Cited: 7
Identifying the mental health burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients in Switzerland: A pilot study
Rahel S. König, Daniel Paris, Marc Sollberger, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27031-e27031
Open Access | Times Cited: 6
Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial
Liang Dai, Zhidong Liu, Wenjuan Zhou, et al.
Phytomedicine (2024) Vol. 129, pp. 155636-155636
Closed Access | Times Cited: 6
Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients
Thomas Vogl, Iris Kalka, Shelley Klompus, et al.
Science Advances (2022) Vol. 8, Iss. 38
Open Access | Times Cited: 23
A roadmap for research in post-stroke fatigue: Consensus-based core recommendations from the third Stroke Recovery and Rehabilitation Roundtable
Coralie English, Dawn B. Simpson, Sandra A. Billinger, et al.
Neurorehabilitation and neural repair (2023) Vol. 38, Iss. 1, pp. 7-18
Open Access | Times Cited: 16
Ginsenoside Rg1 can reverse fatigue behavior in CFS rats by regulating EGFR and affecting Taurine and Mannose 6-phosphate metabolism
Chaofang Lei, Jiaxu Chen, Zhen Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
A roadmap for research in post-stroke fatigue: Consensus-based core recommendations from the third Stroke Recovery and Rehabilitation Roundtable
Coralie English, Dawn B. Simpson, Sandra A. Billinger, et al.
International Journal of Stroke (2023) Vol. 19, Iss. 2, pp. 133-144
Open Access | Times Cited: 14
Synbiotic Supplementation Improves Quality of Life and Inmunoneuroendocrine Response in Patients with Fibromyalgia: Influence of Codiagnosis with Chronic Fatigue Syndrome
María Dolores Hinchado, Carmen Daniela Quero-Calero, Eduardo Otero, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1591-1591
Open Access | Times Cited: 13
Myalgic encephalomyelitis/chronic fatigue syndrome from current evidence to new diagnostic perspectives through skeletal muscle and metabolic disturbances
Tiziana Pietrangelo, Stefano Cagnin, Danilo Bondi, et al.
Acta Physiologica (2024) Vol. 240, Iss. 4
Closed Access | Times Cited: 5
A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID
Joanna Michalina Jurek, Jesús Castro‐Marrero
Nutrients (2024) Vol. 16, Iss. 11, pp. 1545-1545
Open Access | Times Cited: 5
Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery
Franz Martı́n, Manuel Blanco-Suárez, Paola Zambrano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Increased risk of chronic fatigue syndrome following infection: a 17-year population-based cohort study
H.L. Chang, Chien-Feng Kuo, Teng‐Shun Yu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top